The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM

Rheumatology (United Kingdom)

Volumn 51, Issue 7, 2012, Pages 1278-1284

  Koga, Tomohiro ^a   Fujikawa, Keita ^a   Horai, Yoshiro ^a   Okada, Akitomo ^a   Kawashiri, Shin Ya ^a   Iwamoto, Naoki ^a   Suzuki, Takahisa ^a   Nakashima, Yoshikazu ^a   Tamai, Mami ^a   Arima, Kazuhiko ^a   Yamasaki, Satoshi ^a   Nakamura, Hideki ^a   Origuchi, Tomoki ^a   Hamaguchi, Yasuhito ^b   Fujimoto, Manabu ^b   Ishimatsu, Yuji ^a   Mukae, Hiroshi ^c   Kuwana, Masataka ^d   Kohno, Shigeru ^a   Eguchi, Katsumi ^e   Aoyagi, Kiyoshi ^a   Kawakami, Atsushi ^a   more..

^a NAGASAKI UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Sasebo Shiritsu Sogo Hospital   (Japan)

Author keywords

Anti MDA5 Ab; CADM; RPILD

Indexed keywords

ANTI MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 ANTIBODY; ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPRECIPITATION; INTERSTITIAL LUNG DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PAPULE; PNEUMOMEDIASTINUM; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RESPIRATORY FAILURE; SKIN ULCER;

ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; DEAD-BOX RNA HELICASES; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOPRECIPITATION; INCIDENCE; JAPAN; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84863856840     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker518     Document Type: Article

References (23)

1. Yoshifuji H, Fujii T, Kobayashi S et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006;39:233-41.
2. Sato S, Hirakata M, Kuwana M et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005;52:1571-6.
3. Kaji K, Fujimoto M, Hasegawa M et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology 2007;46:25-8.
4. Ge Q, Wu Y, James JA et al. Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen. Arthritis Rheum 1996;39:1588-95.
5. Zhang Y, LeRoy G, Seelig HP et al. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998;95:279-89.
6. Espada G, Maldonado Cocco JA et al. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. J Rheumatol 2009;36:2547-51.
7. Fujikawa K, Kawakami A, Kaji K et al. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a singlecentre, cross-sectional study. Scand J Rheumatol 2009; 38:263-7.
8. Mukae H, Ishimoto H, Sakamoto N et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 2009;136:1341-7.
9. Nakashima R, Imura Y, Kobayashi S et al. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology 2010;49:433-40.
10. Sato S, Hoshino K, Satoh T et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 2009;60: 2193-200.
11. Gono T, Kawaguchi Y, Satoh T et al. Clinical manifestation and prognostic factor in anti-melanoma differentiationassociated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 2010;49:1713-9.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
13. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
14. Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 2002;20:387-408.
15. Gerami P, Schope JM, McDonald L et al. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 2006;54:597-613.
16. Gono T, Kawaguchi Y, Ozeki E et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol 2011;21:223-7.
17. Zandman-Goddard G, Shoenfeld Y. Ferritin in autoimmune diseases. Autoimmun Rev 2007;6:457-63.
18. Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol 2010;22:561-6.
19. Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008;20:17-22.
20. Maakaroun NR, Moanna A, Jacob JT et al. Viral infections associated with haemophagocytic syndrome. Rev Med Virol 2010;20:93-105.
21. Yamasaki Y, Yamada H, Yamasaki M et al. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Rheumatology 2007;46:124-30.
22. Kameda H, Nagasawa H, Ogawa H et al. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 2005;32:1719-26.
23. Nobutoh T, Kohda M, Doi Y et al. An autopsy case of dermatomyositis with rapidly progressive diffuse alveolar damage. J Dermatol 1998;25:32-6.